|Articles|August 1, 2003

Examining the Dyslipidemia Constellation
Volume 9
Issue 1 Dyslipid

Case reports illustrate consequences of ATP III in practice

Author(s)Herbert Schuster, MD

Download PDF: Case reports illustrate consequences of ATP III in practice

Articles in this issue

almost 23 years ago

Article

NCEP ATP III guidelines incorporate global risk assessment

almost 23 years ago

Article

Interview: Intergrating clinical trial results into managed care practice

almost 23 years ago

Article

Inflammatory markers are useful risk assessment tools

almost 23 years ago

Article

Atherosclerosis target of lipid-lowering therapy: Is Lower LDL cholesterol better?

almost 23 years ago

Article

IVUS is redefining atherosclerotic disease

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Case reports illustrate consequences of ATP III in practice

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV

New Bill Would Cap Traditional Medicare Out-of-Pocket Costs at $5000

Topical Delgocitinib Improves Chronic Hand Eczema Outcomes Across All Trial Timepoints

FDA Expands Risankizumab Approval to Pediatric Plaque Psoriasis, Active PsA

Treatment for Thyroid Eye Disease Approved by FDA